alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology

被引:51
|
作者
Eisbach, Sibylle E. [1 ]
Outeiro, Tiago F. [1 ]
机构
[1] Univ Med Ctr Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept Neurodegenerat & Restorat Res, D-37073 Gottingen, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2013年 / 91卷 / 06期
关键词
alpha-Synuclein; Trafficking; Spreading; Prion; Transmission; Parkinson's disease; TO-NEURON TRANSMISSION; N-TERMINAL ACETYLATION; SUBSTANTIA-NIGRA; RAB GTPASES; SYNAPTIC DYSFUNCTION; AXONAL-TRANSPORT; IRON CONTENT; CELL-DEATH; IN-VITRO; MEMBRANE;
D O I
10.1007/s00109-013-1038-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Parkinson's disease is characterized by intracellular proteinaceous depositions known as Lewy bodies. These largely consist of the protein alpha-synuclein, whose physiological function remains unclear, but mutations and overexpression of the protein have been shown to cause early onset cases of Parkinson's disease. Deregulation of alpha-synuclein biology causes neurodegeneration and impaired neuronal trafficking, hinting at a possible contribution to the pathological mechanism. Recent studies produced some evidence hinting at the involvement of several regulators of the transport machinery such as Rab GTPases and SNARE proteins, but also shown that alpha-synuclein can be propagated between cells. Here, we discuss the molecular interplay of alpha-synuclein with the intracellular transport machinery, its consequences, and the implications for disease mechanisms.
引用
收藏
页码:693 / 703
页数:11
相关论文
共 50 条
  • [21] The Role of Astrocytes and Alpha-Synuclein in Parkinson's Disease: A Review
    Brash-Arias, David
    Garcia, Luis I.
    Perez-Estudillo, Cesar Antonio
    Rojas-Duran, Fausto
    Aranda-Abreu, Gonzalo Emiliano
    Herrera-Covarrubias, Deissy
    Chi-Castaneda, Donaji
    NEUROSCI, 2024, 5 (01): : 71 - 86
  • [22] Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson's Disease
    Graciela Cersosimo, Maria
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2015, 2015
  • [23] New Perspectives on Roles of Alpha-Synuclein in Parkinson's Disease
    Zhang, Guoxin
    Xia, Yun
    Wan, Fang
    Ma, Kai
    Guo, Xingfang
    Kou, Liang
    Yin, Sijia
    Han, Chao
    Liu, Ling
    Huang, Jinsha
    Xiong, Nian
    Wang, Tao
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [24] The Role of Microglia and Astrocytes in the Pathomechanism of Neuroinflammation in Parkinson's Disease-Focus on Alpha-Synuclein
    Harackiewicz, Oliwia
    Grembecka, Beata
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2024, 23 (11)
  • [25] Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson's disease
    Otero-Jimenez, Maria
    Wojewska, Marcelina J.
    Binding, Lawrence P.
    Jogaudaite, Simona
    Gray-Rodriguez, Sandra
    Young, Alexandra L.
    Gentleman, Steve
    Alegre-Abarrategui, Javier
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2025, 13 (01):
  • [26] Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson Disease
    Dolgacheva, L. P.
    Fedotova, E. I.
    Abramov, A. Y.
    Berezhnov, A. V.
    BIOLOGICHESKIE MEMBRANY, 2017, 34 (05): : 4 - 14
  • [27] Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain
    Roberts, Rosalind F.
    Wade-Martins, Richard
    Alegre-Abarrategui, Javier
    BRAIN, 2015, 138 : 1642 - 1657
  • [28] Modeling Parkinson's Disease With the Alpha-Synuclein Protein
    Gomez-Benito, Monica
    Granado, Noelia
    Garcia-Sanz, Patricia
    Michel, Anne
    Dumoulin, Mireille
    Moratalla, Rosario
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [29] Autoantibodies to alpha-synuclein in inherited Parkinson's disease
    Papachroni, Katerina K.
    Ninkina, Natalia
    Papapanagiotou, Angeliki
    Hadjigeorgiou, Georgios M.
    Xiromerisiou, Georgia
    Papadimitriou, Alexandros
    Kalofoutis, Anastasios
    Buchman, Vladimir L.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 (03) : 749 - 756
  • [30] Targeting Alpha-Synuclein for the Treatment of Parkinson's Disease
    Rohn, Troy T.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (02) : 174 - 179